Drug Profile
WIN 70197
Alternative Names: WIN-70197Latest Information Update: 08 Sep 2006
Price :
$50
*
At a glance
- Originator Amersham Health; Sanofi Winthrop
- Class Gadolinium-containing contrast agents; Radiopharmaceuticals
- Mechanism of Action Magnetic resonance imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Liver disorders
Most Recent Events
- 08 Sep 2006 Discontinued - Preclinical for Liver disorders diagnosis in USA (unspecified route)
- 16 Nov 1998 No development reported - Preclinical for Liver disorders diagnosis in USA (unspecified route)
- 24 Jan 1997 Preclinical development for Liver disorders diagnosis in USA (unspecified route)